Globe Life Inc. (GL) experienced a significant price surge of 5.21% during Thursday's intraday trading session, reflecting strong investor interest in the insurance provider.

The upward movement appears to be driven by positive analyst sentiment and encouraging business performance metrics. JPMorgan analyst Jimmy Bhullar raised the firm's price target on Globe Life to $181 from $180 while maintaining an Overweight rating on the shares, signaling continued confidence in the company's prospects.

Additionally, Globe Life recently reported its fourth-quarter and full-year 2025 results, showing robust growth in key business segments. The company achieved a 71% increase in health insurance net sales and an 11% rise in life insurance net sales during the quarter, despite earnings coming in slightly below analyst expectations. The completion of a long-running share repurchase program totaling approximately $10 billion since 2005 further supports the company's disciplined capital return strategy.